Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MicroRNA expression profile in granulocytes from primary myelofibrosis patients.
Guglielmelli P, Tozzi L, Pancrazzi A, Bogani C, Antonioli E, Ponziani V, Poli G, Zini R, Ferrari S, Manfredini R, Bosi A, Vannucchi AM; MPD Research Consortium. Guglielmelli P, et al. Among authors: bosi a. Exp Hematol. 2007 Nov;35(11):1708-18. doi: 10.1016/j.exphem.2007.08.020. Exp Hematol. 2007. PMID: 17976522 Free article.
Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia.
Antonioli E, Carobbio A, Pieri L, Pancrazzi A, Guglielmelli P, Delaini F, Ponziani V, Bartalucci N, Tozzi L, Bosi A, Rambaldi A, Barbui T, Vannucchi AM. Antonioli E, et al. Among authors: bosi a. Haematologica. 2010 Aug;95(8):1435-8. doi: 10.3324/haematol.2009.021444. Epub 2010 Apr 23. Haematologica. 2010. PMID: 20418246 Free PMC article. No abstract available.
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations.
Pennucci V, Zini R, Norfo R, Guglielmelli P, Bianchi E, Salati S, Sacchi G, Prudente Z, Tenedini E, Ruberti S, Paoli C, Fanelli T, Mannarelli C, Tagliafico E, Ferrari S, Vannucchi AM, Manfredini R; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) Investigators. Pennucci V, et al. Leuk Lymphoma. 2015 Feb;56(2):492-6. doi: 10.3109/10428194.2014.910661. Epub 2014 Jun 16. Leuk Lymphoma. 2015. PMID: 24707949 No abstract available.
JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis.
Guglielmelli P, Barosi G, Pieri L, Antonioli E, Bosi A, Vannucchi AM. Guglielmelli P, et al. Among authors: bosi a. Haematologica. 2009 Jan;94(1):144-6. doi: 10.3324/haematol.13721. Epub 2008 Nov 27. Haematologica. 2009. PMID: 19042918 Free PMC article. No abstract available.
Insights into JAK2-V617F mutation in CML.
Bocchia M, Vannucchi AM, Gozzetti A, Guglielmelli P, Poli G, Crupi R, Defina M, Bosi A, Francesco L. Bocchia M, et al. Among authors: bosi a. Lancet Oncol. 2007 Oct;8(10):864-6. doi: 10.1016/S1470-2045(07)70295-4. Lancet Oncol. 2007. PMID: 17913657 No abstract available.
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia.
Antonioli E, Guglielmelli P, Poli G, Bogani C, Pancrazzi A, Longo G, Ponziani V, Tozzi L, Pieri L, Santini V, Bosi A, Vannucchi AM; Myeloproliferative Disorders Research Consortium (MPD-RC). Antonioli E, et al. Among authors: bosi a. Haematologica. 2008 Jan;93(1):41-8. doi: 10.3324/haematol.11653. Haematologica. 2008. PMID: 18166784 Free article.
448 results